Table of Contents
Pathology Research International
Volume 2011, Article ID 504940, 7 pages
http://dx.doi.org/10.4061/2011/504940
Review Article

Issues Related to Sentinel Lymph Node Assessment in the Management of Breast Cancer—What Are Relevant in Pathology Reports?

1Department of Radiation Oncology, Allan Blair Cancer Center, SK, Canada S4T 7T1
2Department of Oncology, Cross Cancer Center, AB, Canada T6G 1Z2
3Radiation Oncology Division, London Regional Cancer Program, ON, Canada N5A 4L6

Received 12 September 2010; Accepted 19 January 2011

Academic Editor: Sunati Sahoo

Copyright © 2011 Patricia Tai et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. http://www.cancer.ca/.
  2. P. T. Truong, E. Berthelet, J. Lee, H. A. Kader, and I. A. Olivotto, “The prognostic significance of the percentage of positive/dissected axillary lymph nodes in breast cancer recurrence and survival in patients with one to three positive axillary lymph nodes,” Cancer, vol. 103, no. 10, pp. 2006–2014, 2005. View at Publisher · View at Google Scholar · View at Scopus
  3. M. Voordeckers, V. Vinh-Hung, J. van de Steene, J. Lamote, and G. Storme, “The lymph node ratio as prognostic factor in node-positive breast cancer,” Radiotherapy and Oncology, vol. 70, no. 3, pp. 225–230, 2004. View at Publisher · View at Google Scholar · View at Scopus
  4. B. C. H. van der Wal, R. M. J. M. Butzelaar, S. van der Meij, and M. A. Boermeester, “Axillary lymph node ratio and total number of removed lymph nodes: predictors of survival in stage I and II breast cancer,” European Journal of Surgical Oncology, vol. 28, no. 5, pp. 481–489, 2002. View at Publisher · View at Google Scholar · View at Scopus
  5. Y. Nieto, P. J. Cagnoni, E. J. Shpall et al., “A predictive model for relapse in high-risk primary breast cancer patients treated with high-dose chemotherapy and autologous stem-cell transplant,” Clinical Cancer Research, vol. 5, no. 11, pp. 3425–3431, 1999. View at Google Scholar · View at Scopus
  6. L. J. Megale Costa, H. Prado Soares, H. Amaral Gaspar et al., “Ratio between positive lymph nodes and total dissected axillaries lymph nodes as an independent prognostic factor for disease-free survival in patients with breast cancer,” American Journal of Clinical Oncology, vol. 27, no. 3, pp. 304–306, 2004. View at Publisher · View at Google Scholar
  7. J. Martinez-Trufero, A. Artal-Cortes, M. Zorrilla et al., “New distinctive features on the study of prognostic factors in patients with locally advanced breast cancer (LABC) treated with neoadjuvant chemotherapy (NAC),” Proceedings of the American Society of Clinical Oncology, vol. 20, abstract 3069, 2001. View at Google Scholar
  8. W. A. Woodward, V. Vinh-Hung, N. T. Ueno et al., “Prognostic value of nodal ratios in node-positive breast cancer,” Journal of Clinical Oncology, vol. 24, no. 18, pp. 2910–2916, 2006. View at Publisher · View at Google Scholar · View at Scopus
  9. E. Yildirim and U. Berberoglu, “Lymph node ratio is more valuable than level III involvement for prediction of outcome in node-positive breast carcinoma patients,” World Journal of Surgery, vol. 31, no. 2, pp. 276–289, 2007. View at Publisher · View at Google Scholar · View at Scopus
  10. B. Keam, S. A. Im, H. J. Kim et al., “Clinical significance of axillary nodal ratio in stage II/III breast cancer treated with neoadjuvant chemotherapy,” Breast Cancer Research and Treatment, vol. 116, no. 1, pp. 153–160, 2009. View at Publisher · View at Google Scholar · View at Scopus
  11. P. Tai, K. Joseph, E. Sadikov, S. Mahmood, F. Lien, and E. Yu, “Nodal ratios in node-positive breast cancer-long-term study to clarify discrepancy of role of supraclavicular and axillary regional radiotherapy,” International Journal of Radiation Oncology Biology Physics, vol. 68, no. 3, pp. 662–666, 2007. View at Publisher · View at Google Scholar · View at Scopus
  12. S. A. Joslyn and B. R. Konety, “Effect of axillary lymphadenectomy on breast carcinoma survival,” Breast Cancer Research and Treatment, vol. 91, no. 1, pp. 11–18, 2005. View at Publisher · View at Google Scholar · View at Scopus
  13. K. A. Vanderveen, P. D. Schneider, V. P. Khatri, J. E. Goodnight, and R. J. Bold, “Upstaging and improved survival of early breast cancer patients after implementation of sentinel node biopsy for axillary staging,” Annals of Surgical Oncology, vol. 13, no. 11, pp. 1450–1456, 2006. View at Publisher · View at Google Scholar · View at Scopus
  14. J. C. Tille, J. F. Egger, M. C. Devillaz, G. Vlastos, and M. F. Pelte, “Frozen section in axillary sentinel lymph nodes for diagnosis of breast cancer micrometastasis,” Anticancer Research, vol. 29, no. 11, pp. 4711–4716, 2009. View at Google Scholar · View at Scopus
  15. D. L. Weaver, “Pathology evaluation of sentinel lymph nodes in breast cancer: protocol recommendations and rationale,” Modern Pathology, vol. 23, no. 2, pp. S26–S32, 2010. View at Publisher · View at Google Scholar · View at Scopus
  16. American Joint Committee on Cancer (AJCC) Cancer Staging Manual, Springer, New York, NY, USA, 7th edition, 2010.
  17. D. F. Hayes, “Tumor node metastasis (TNM) staging classification for breast cancer,” in UpToDate, B. D. Rose, Ed., UpToDate, Waltham, Mass, USA, 2010. View at Google Scholar
  18. C. S. E. Bulte, M. van der Heiden-van der Loo, and A. Hennipman, “Axillary recurrence rate after tumour negative and micrometastatic positive sentinel node procedures in breast cancer patients, a population based multicenter study,” European Journal of Surgical Oncology, vol. 35, no. 1, pp. 25–31, 2009. View at Publisher · View at Google Scholar · View at Scopus
  19. P. J. Hainsworth, J. J. Tjandra, R. G. Stillwell et al., “Detection and significance of occult metastases in node-negative breast cancer,” British Journal of Surgery, vol. 80, no. 4, pp. 459–463, 1993. View at Google Scholar · View at Scopus
  20. P. T. Truong, V. Vinh-Hung, G. Cserni, W. A. Woodward, P. Tai, and G. Vlastos, “The number of positive nodes and the ratio of positive to excised nodes are significant predictors of survival in women with micrometastatic node-positive breast cancer,” European Journal of Cancer, vol. 44, no. 12, pp. 1670–1677, 2008. View at Publisher · View at Google Scholar
  21. M. de Boer, C. H. M. van Deurzen, J. A. A. M. van Dijck et al., “Micrometastases or isolated tumor cells and the outcome of breast cancer,” The New England Journal of Medicine, vol. 361, no. 7, pp. 653–663, 2009. View at Publisher · View at Google Scholar · View at Scopus
  22. S. L. Chen, F. M. Hoehne, and A. E. Giuliano, “The prognostic significance of micrometastases in breast cancer: a SEER population-based analysis,” Annals of Surgical Oncology, vol. 14, no. 12, pp. 3378–3384, 2007. View at Publisher · View at Google Scholar · View at Scopus
  23. D. Grabau, M. B. Jensen, F. Rank, and M. Blichert-Toft, “Axillary lymph node micrometastases in invasive breast cancer: national figures on incidence and overall survival,” APMIS, vol. 115, no. 7, pp. 828–837, 2007. View at Publisher · View at Google Scholar · View at Scopus
  24. G. P. Kuijt, A. C. Voogd, L. V. van de Poll-Franse, L. J. E. E. Scheijmans, M. W. P. M. van Beek, and R. M. H. Roumen, “The prognostic significance of axillary lymph-node micrometastases in breast cancer patients,” European Journal of Surgical Oncology, vol. 31, no. 5, pp. 500–505, 2005. View at Publisher · View at Google Scholar · View at Scopus
  25. D. C. Maibenco, G. W. Dombi, T. Y. Kau, and R. K. Severson, “Significance of micrometastases on the survival of women with T1 breast cancer,” Cancer, vol. 107, no. 6, pp. 1234–1239, 2006. View at Publisher · View at Google Scholar · View at Scopus
  26. Y. G. Fan, Y. Y. Tan, C. T. Wu et al., “The effect of sentinel node tumor burden on non-sentinel node status and recurrence rates in breast cancer,” Annals of Surgical Oncology, vol. 12, no. 9, pp. 705–711, 2005. View at Publisher · View at Google Scholar · View at Scopus
  27. C. E. Cox, J. V. Kiluk, A. I. Riker et al., “Significance of sentinel lymph node micrometastases in human breast cancer,” Journal of the American College of Surgeons, vol. 206, no. 2, pp. 261–268, 2008. View at Publisher · View at Google Scholar · View at Scopus
  28. P. D. Gobardhan, S. G. Elias, E. V. E. Madsen et al., “Prognostic value of micrometastases in sentinel lymph nodes of patients with breast carcinoma: a cohort study,” Annals of Oncology, vol. 20, no. 1, pp. 41–48, 2009. View at Publisher · View at Google Scholar · View at Scopus
  29. M. Colleoni, N. Rotmensz, G. Peruzzotti et al., “Size of breast cancer metastases in axillary lymph nodes: clinical relevance of minimal lymph node involvement,” Journal of Clinical Oncology, vol. 23, no. 7, pp. 1379–1389, 2005. View at Publisher · View at Google Scholar · View at Scopus
  30. A. J. Maaskant-Braat, L. V. van de Poll-Franse, A. C. Voogd et al., “SN micrometastases in breast cancer do not affect prognosis, a population-based study,” Breast Cancer Research and Treatment. In press.
  31. L. H. Sobin and C. Wittekind, Eds., TNM Classification of Malignant Tumours, Wiley-Liss, New York, NY, USA, 6th edition, 2002.
  32. J. M. Cordero García, M. Delgado Portela, A. M. García Vicente et al., “Micrometastasis in the sentinel node and axillary lymph node macrometastasis in breast cancer,” Revista Espanola de Medicina Nuclear, vol. 29, no. 3, pp. 122–126, 2010. View at Publisher · View at Google Scholar · View at Scopus
  33. G. Houvenaeghel, C. Nos, H. Mignotte et al., “Micrometastases in sentinel lymph node in a multicentric study: predictive factors of nonsentinel lymph node involvement—Groupe des Chirurgiens de la Federation des Centres de Lutte Contre Le Cancer,” Journal of Clinical Oncology, vol. 24, no. 12, pp. 1814–1822, 2006. View at Publisher · View at Google Scholar · View at Scopus
  34. E. M. Barbosa, A. A. R. F. Francisco, J. T. Araujo Neto, E. M. F. Alves, M. G. M. Tavares, and J. C. S. Góes, “Clinicopathological predictor factors of axillary involvement in patients with metastatic breast cancer in the sentinel lymph node,” Revista Brasileira de Ginecologia e Obstetricia, vol. 32, no. 3, pp. 144–149, 2010. View at Google Scholar · View at Scopus
  35. S. Kumar, M. Bramlage, L. M. Jacks et al., “Minimal disease in the sentinel lymph node: how to best measure sentinel node micrometastases to predict risk of additional non-sentinel lymph node disease,” Annals of Surgical Oncology, vol. 17, no. 11, pp. 2909–2919, 2010. View at Publisher · View at Google Scholar · View at Scopus
  36. W. P. Olszewski, A. Szumera-Ciećkiewicz, J. Piechocki, E. Towpik, and W. T. Olszewski, “The characteristics of the sentinel lymph node metastasis in predicting the axillary lymph node status in patients with breast carcinoma,” Polish Journal of Pathology, vol. 60, no. 3, pp. 138–143, 2009. View at Google Scholar · View at Scopus
  37. K. J. van Zee, D. M. E. Manasseh, J. L. B. Bevilacqua et al., “A nomogram for predicting the likelihood of additional nodal metastases in breast cancer patients with a positive sentinel node biopsy,” Annals of Surgical Oncology, vol. 10, no. 10, pp. 1140–1151, 2003. View at Publisher · View at Google Scholar · View at Scopus
  38. E. Barranger, C. Coutant, A. Flahault, Y. Delpech, E. Darai, and S. Uzan, “An axilla scoring system to predict non-sentinel lymph node status in breast cancer patients with sentinel lymph node involvement,” Breast Cancer Research and Treatment, vol. 91, no. 2, pp. 113–119, 2005. View at Publisher · View at Google Scholar · View at Scopus
  39. Y. Y. Tan, Y. G. Fan, Y. Lu et al., “Ratio of positive to total number of sentinel nodes predicts nonsentinel node status in breast cancer patients,” Breast Journal, vol. 11, no. 4, pp. 248–253, 2005. View at Publisher · View at Google Scholar · View at Scopus
  40. S. M. Giobuin, D. O. Kavanagh, E. Myers et al., “The significance of immunohistochemistry positivity in sentinel nodes which are negative on haematoxylin and eosin in breast cancer,” European Journal of Surgical Oncology, vol. 35, no. 12, pp. 1257–1260, 2009. View at Publisher · View at Google Scholar · View at Scopus
  41. A. E. Giuliano, L. M. McCall, P. D. Beitsch et al., “ACOSOG Z0011: a randomized trial of axillary node dissection in women with clinical T1-2 N0 M0 breast cancer who have a positive SN,” Journal of Clinical Oncology, vol. 28, p. 18s, abstract CRA506, 2010. View at Google Scholar
  42. O. Abe, R. Abe, K. Enomoto et al., “Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomised trials,” The Lancet, vol. 366, no. 9503, pp. 2087–2106, 2005. View at Publisher · View at Google Scholar